Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure.
暂无分享,去创建一个
[1] E. Braunwald,et al. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure. , 1981, American heart journal.
[2] M. Weinberger,et al. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure. , 1981, The American journal of medicine.
[3] N. Hollenberg,et al. Relation of the Renin‐Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure , 1981, Circulation.
[4] R. Alexander,et al. Regulation of the Postsynaptic α‐Adrenergic Receptor in Rat Mesenteric Artery: Effects of Chemical Sympathectomy and Epinephrine Treatment 1981 , 1981, Circulation research.
[5] C. Desch,et al. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure. , 1980, The American journal of cardiology.
[6] E. Neer,et al. Evidence for uncoupling of the beta receptor-adenylate cyclase complex. , 1980, Circulation research.
[7] E. Braunwald,et al. Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. , 1980, Annals of internal medicine.
[8] N. Hollenberg,et al. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. , 1980, The New England journal of medicine.
[9] N. Hollenberg,et al. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. , 1980, The Journal of clinical investigation.
[10] M. Blaustein,et al. The Role of the Sodium Pump in the Control of Vascular Tone in the Rat , 1980, Circulation research.
[11] F. Magrini,et al. Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema. , 1980, The American journal of cardiology.
[12] J. Cohn,et al. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. , 1980, The American journal of cardiology.
[13] J. Parker,et al. Tolerance to the Circulatory Effects of Oral Isosorbide Dinitrate: Rate of Development and Cross–tolerance to Glyceryl Trinitrate , 1980, Circulation.
[14] R. Alexander,et al. Characterization of Postsynaptic Alpha‐Adrenergic Receptors by [8H]‐Dihydroergocryptine Binding in Muscular Arteries from the Rat Mesentery , 1980, Hypertension.
[15] J. Cohn,et al. Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure. , 1980, The American journal of cardiology.
[16] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[17] S. Ayres,et al. Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. , 1980, The Journal of clinical investigation.
[18] J. Cohn,et al. Effect of Hydralazine on Renal Failure in Patients with Congestive Heart Failure , 1980, Circulation.
[19] L. Johnson,et al. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. , 1980, The American journal of medicine.
[20] R. Gorlin,et al. Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure. , 1979, The New England journal of medicine.
[21] J. Cohn,et al. Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart. , 1979, The American journal of cardiology.
[22] C. Johnston,et al. LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION , 1979, The Lancet.
[23] L. Benet,et al. Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.
[24] R. Lefkowitz. Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications. , 1979, Annals of internal medicine.
[25] E. Sonnenblick,et al. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.
[26] W. Pettinger,et al. Effects of Prazosin and Phentolamine on Arterial Pressure, Heart Rate, and Renin Activity: Evidence in the Conscious Rat for the Functional Significance of the Presynaptic α-Receptor , 1979, Journal of cardiovascular pharmacology.
[27] E. Sonnenblick,et al. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. , 1979, The New England journal of medicine.
[28] K. Catt,et al. Hormonal regulation of peptide receptors and target cell responses , 1979, Nature.
[29] R. Zelis,et al. How much can we expect from vasodilator therapy in congestive heart failure? , 1979, Circulation.
[30] R. Lefkowitz,et al. Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. , 1979, Life sciences.
[31] B. Brundage,et al. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.
[32] G. Nicolosi,et al. Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes. , 1979, Biochemical pharmacology.
[33] R. Gorlin,et al. Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.
[34] W. Pettinger,et al. Drug therapy. Prazosin. , 1979, The New England journal of medicine.
[35] W. Aronow,et al. Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.
[36] J. Cohn,et al. Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.
[37] H. Gavras,et al. Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade. , 1978, British heart journal.
[38] M. Packer,et al. Oral vasodilator therapy for chronic heart failure: a plea for caution. , 1978, The American journal of cardiology.
[39] J. Goodwin,et al. Beneficial Effect of Salbutamol on Cardiac Function in Severe Congestive Cardiomyopathy: Effect on Systolic and Diastolic Function of the Left Ventricle , 1978, Circulation.
[40] J. Wikberg. Pharmacological classification of adrenergic α receptors in the guinea pig , 1978, Nature.
[41] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[42] E. Braunwald,et al. Hemodynamic Effects of Intravenous Sodium Nitroprusside in the Conscious Dog , 1978, Circulation.
[43] J. Cohn,et al. Contrasting effect of vasodilators on heart rate and plasma catecholamines in patients with hypertension and heart failure , 1978 .
[44] W. Pettinger,et al. A functional basis for classification of α-adrenergic receptors , 1977 .
[45] R. Miller,et al. Efficacy of Ambulatory Systemic Vasodilator Therapy with Oral Prazosin in Chronic Refractory Heart Failure: Concomitant Relief of Pulmonary Congestion and Elevation of Pump Output Demonstrated by Improvements in Symptomatology, Exercise Tolerance, Hemodynamics and Echocardiography , 1977, Circulation.
[46] E. Braunwald. Vasodilator therapy--a physiologic approach to the treatment of heart failure. , 1977, The New England journal of medicine.
[47] J. Cohn,et al. Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.
[48] W. Aronow. Hemodynamics and Antianginal Effects of High Dose Oral Isosorbide Dinitrate After Chronic Use , 1977, Circulation.
[49] N. Hollenberg,et al. Accentuated vascular and endocrine response to SQ 20881 in hypertension. , 1977, The New England journal of medicine.
[50] J. Cohn,et al. Vasodilator Therapy of Cardiac Failure , 1977 .
[51] B. Massie,et al. Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.
[52] J. Diamond,et al. Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery. , 1976, Molecular pharmacology.
[53] F. Smith,et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. , 1976, The Journal of clinical investigation.
[54] W. Campbell,et al. Evidence for a Renal α‐Adrenergic Receptor Inhibiting Renin Release , 1976, Circulation research.
[55] K. Shine,et al. Vasodilator Therapy for Chronic Left Ventricular Failure , 1976, Circulation.
[56] M. Caron,et al. Regulation of adenylate cyclase coupled beta-adrenergic receptors. , 1976, Recent progress in hormone research.
[57] S. Z. Langer. The Role of α- and β-Presynaptic Receptors in the Regulation of Noradrenaline Release Elicited by Nerve Stimulation , 1976 .
[58] J. Brundin,et al. Dual Adrenoceptor‐mediated Control of Noradrenaline Secretion from Human Vasoconstrictor Nerves: Facilitation by β‐receptors and Inhibition by α‐receptors , 1975 .
[59] W. Pettinger,et al. Altered renin release and propranolol potentiation of vasodilatory drug hypotension. , 1975, The Journal of clinical investigation.
[60] J. Laragh,et al. Prior Receptor Occupancy as a Determinant of the Pressor Activity of Infused Angiotensin II in the Rat , 1975, Circulation research.
[61] J. Cohn,et al. Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.
[62] R. Zelis. The contribution of local factors to the elevated venous tone of congestive heart failure. , 1974, The Journal of clinical investigation.
[63] S. Z. Langer,et al. Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.
[64] J. Koch-weser. Vasodilation for Vasospastic Hypertension , 1973 .
[65] W. Campbell,et al. Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat , 1973, Circulation research.
[66] J. Henry,et al. Impaired Atrial Receptor Responses in Dogs with Heart Failure Due to Tricuspid Insufficiency and Pulmonary Artery Stenosis , 1973, Circulation research.
[67] P. Needleman,et al. Mechanism of tolerance development to organic nitrates. , 1973, The Journal of pharmacology and experimental therapeutics.
[68] Oxon Ma. Gerald Legh Malins McElligott. , 1972 .
[69] C. Higgins,et al. Effects of Experimentally Produced Heart Failure on the Peripheral Vascular Response to Severe Exercise in Conscious Dogs , 1972, Circulation research.
[70] E. Braunwald,et al. Alterations in the baroreceptor reflex in conscious dogs with heart failure. , 1972, The Journal of clinical investigation.
[71] S. Taylor,et al. Phentolamine for vasodilator treatment of severe heart-failure. , 1971, Lancet.
[72] B. Waldeck,et al. Inhibitory effect of propranolol on the vasoconstrictor response to sympathetic nerve stimulation , 1970, The Journal of pharmacy and pharmacology.
[73] W. Aronow,et al. Evaluation of Nitroglycerin in Angina in Patients on Isosorbide Dinitrate , 1970, Circulation.
[74] J. Weil,et al. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. , 1970, The New England journal of medicine.
[75] R. Zelis,et al. Arterial sodium content in experimental congestive heart failure. , 1970 .
[76] E. Braunwald,et al. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. , 1968, The Journal of clinical investigation.
[77] Y. Kaneko,et al. Renin release during acute reduction of arterial pressure in normotensive subjects and patients with renovascular hypertension. , 1967, The Journal of clinical investigation.
[78] L. Lasagna,et al. A study of cross‐tolerance to circulatory effects of organic nitrates , 1967, Clinical pharmacology and therapeutics.
[79] E. Braunwald,et al. CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.
[80] E. Braunwald,et al. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.
[81] D. T. Walz,et al. ISOPROTERENOL VASOMOTOR REVERSAL BY SYMPATHOMIMETIC AMINES , 1960, The Journal of pharmacology and experimental therapeutics.
[82] A. M. Schwartz. The cause, relief and prevention of headaches arising from contact with dynamite. , 1946, The New England journal of medicine.